Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device
Authors not listed
Optimal Acuity Corporation · 2020
Abstract
The purpose of this study is to assess the vision improvement achieved by patients with late stage dry age-related macular degeneration who received corneal treatments by a low vision aid device.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2020). Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device. <em>Optimal Acuity Corporation</em>. https://clinicaltrials.gov/study/NCT04349254
Vancouver
Anonymous. Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device. Optimal Acuity Corporation. 2020.
BibTeX
@misc{anon2020Observ,
title = {Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device},
author = {Anonymous},
journal = {Optimal Acuity Corporation},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Optimal Acuity Corporation 2021
Open access · US-GOV
Observational Study of Vision Improvement in Patients With Retinal Disorders
VIS, Inc. 2025
Open access · US-GOV
Vision Improvement for Patients With Age-Related Macular Degeneration
US Department of Veterans Affairs 2005
Open access · US-GOV
Measuring Reading Rehabilitation Outcomes
IRCCS San Raffaele 2011
Open access · US-GOV
Intravitreal Bevacizumab for the Treatment of Patients With Low Vision Due to Neovascular Age-related Macular Degeneration
OccuLogix 2005
Open access · US-GOV
A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)
Chengdu Kanghong Biotech Co., Ltd. 2011
Open access · US-GOV